TR200100622T2 - NAB1 ve NAB2'nin farmasötik kullanımları - Google Patents

NAB1 ve NAB2'nin farmasötik kullanımları

Info

Publication number: TR200100622T2
Authority: TR; Turkey
Prior art keywords: nab1; nab2; pharmaceutical uses; polypeptide; polypeptides
Prior art date: 1998-07-11

Application number

TR2001/00622T

Other languages

English (en)

Turkish (tr)

Inventor

Braddock Martin

Jeffrey Campbell Callum

Original Assignee

Glaxo Group Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-07-11

Filing date

1999-07-09

Publication date

2001-10-22

1998-07-11 Priority claimed from GBGB9814989.1A external-priority patent/GB9814989D0/en

1998-09-12 Priority claimed from GBGB9819826.0A external-priority patent/GB9819826D0/en

1999-07-09 Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited

2001-10-22 Publication of TR200100622T2 publication Critical patent/TR200100622T2/xx

Links

101000583053 Homo sapiens NGFI-A-binding protein 1 Proteins 0.000 title abstract 2
101000583057 Homo sapiens NGFI-A-binding protein 2 Proteins 0.000 title abstract 2
CZSLEMCYYGEGKP-UHFFFAOYSA-N N-(2-chlorobenzyl)-1-(2,5-dimethylphenyl)benzimidazole-5-carboxamide Chemical compound CC1=CC=C(C)C(N2C3=CC=C(C=C3N=C2)C(=O)NCC=2C(=CC=CC=2)Cl)=C1 CZSLEMCYYGEGKP-UHFFFAOYSA-N 0.000 title abstract 2
102100030407 NGFI-A-binding protein 1 Human genes 0.000 title abstract 2
102100030391 NGFI-A-binding protein 2 Human genes 0.000 title abstract 2
229920001184 polypeptide Polymers 0.000 abstract 3
108090000765 processed proteins & peptides Proteins 0.000 abstract 3
102000004196 processed proteins & peptides Human genes 0.000 abstract 3
241000124008 Mammalia Species 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
239000012634 fragment Substances 0.000 abstract 1
238000001415 gene therapy Methods 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
108020004707 nucleic acids Proteins 0.000 abstract 1
102000039446 nucleic acids Human genes 0.000 abstract 1
150000007523 nucleic acids Chemical class 0.000 abstract 1
230000029663 wound healing Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Dermatology (AREA)
Marine Sciences & Fisheries (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biotechnology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

TR2001/00622T 1998-07-11 1999-07-09 NAB1 ve NAB2'nin farmasötik kullanımları TR200100622T2 (tr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9814989.1A GB9814989D0 (en)	1998-07-11	1998-07-11	Gene therapy method
GBGB9819826.0A GB9819826D0 (en)	1998-09-12	1998-09-12	Gene therapy method

Publications (1)

Publication Number	Publication Date
TR200100622T2 true TR200100622T2 (tr)	2001-10-22

Family

ID=26314007

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TR2001/00622T TR200100622T2 (tr)	1998-07-11	1999-07-09	NAB1 ve NAB2'nin farmasötik kullanımları

Country Status (22)

Country	Link
EP (1)	EP1097200A1 (is)
JP (1)	JP2002520020A (is)
KR (1)	KR20010071832A (is)
CN (1)	CN1317045A (is)
AP (1)	AP2001002038A0 (is)
AU (1)	AU763713B2 (is)
BR (1)	BR9912018A (is)
CA (1)	CA2336805A1 (is)
EA (1)	EA200100028A1 (is)
EE (1)	EE200100020A (is)
HR (1)	HRP20010025A2 (is)
HU (1)	HUP0102835A3 (is)
ID (1)	ID27742A (is)
IL (1)	IL140533A0 (is)
IS (1)	IS5788A (is)
NO (1)	NO20010166L (is)
NZ (1)	NZ509174A (is)
PL (1)	PL345507A1 (is)
SK (1)	SK382001A3 (is)
TR (1)	TR200100622T2 (is)
WO (1)	WO2000003014A1 (is)
YU (1)	YU1901A (is)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9928430D0 (en) *	1999-12-01	2000-01-26	Glaxo Group Ltd	Screening
WO2002022176A1 (en)	2000-09-15	2002-03-21	Genvec, Inc.	Method of modulating neovascularization
WO2004083435A1 (en) *	2003-03-17	2004-09-30	Julius-Maximilians-Uni Versität Würzburg	Nab proteins and their use in diagnostic and therapeutic applications in heart disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5036006A (en) *	1984-11-13	1991-07-30	Cornell Research Foundation, Inc.	Method for transporting substances into living cells and tissues and apparatus therefor
US5697901A (en) *	1989-12-14	1997-12-16	Elof Eriksson	Gene delivery by microneedle injection

1999
- 1999-07-09 EE EEP200100020A patent/EE200100020A/xx unknown
- 1999-07-09 AP APAP/P/2001/002038A patent/AP2001002038A0/en unknown
- 1999-07-09 IL IL14053399A patent/IL140533A0/xx unknown
- 1999-07-09 AU AU47914/99A patent/AU763713B2/en not_active Ceased
- 1999-07-09 TR TR2001/00622T patent/TR200100622T2/xx unknown
- 1999-07-09 HR HR20010025A patent/HRP20010025A2/hr not_active Application Discontinuation
- 1999-07-09 HU HU0102835A patent/HUP0102835A3/hu unknown
- 1999-07-09 KR KR1020017000413A patent/KR20010071832A/ko not_active Withdrawn
- 1999-07-09 NZ NZ509174A patent/NZ509174A/en unknown
- 1999-07-09 CN CN99810616A patent/CN1317045A/zh active Pending
- 1999-07-09 EP EP99931378A patent/EP1097200A1/en not_active Withdrawn
- 1999-07-09 ID IDW20010345A patent/ID27742A/id unknown
- 1999-07-09 PL PL99345507A patent/PL345507A1/xx not_active Application Discontinuation
- 1999-07-09 EA EA200100028A patent/EA200100028A1/ru unknown
- 1999-07-09 JP JP2000559235A patent/JP2002520020A/ja active Pending
- 1999-07-09 BR BR9912018-6A patent/BR9912018A/pt not_active IP Right Cessation
- 1999-07-09 YU YU1901A patent/YU1901A/sh unknown
- 1999-07-09 WO PCT/GB1999/002199 patent/WO2000003014A1/en not_active Ceased
- 1999-07-09 CA CA002336805A patent/CA2336805A1/en not_active Abandoned
- 1999-07-09 SK SK38-2001A patent/SK382001A3/sk unknown
2000
- 2000-12-22 IS IS5788A patent/IS5788A/is unknown
2001
- 2001-01-10 NO NO20010166A patent/NO20010166L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
SK382001A3 (en)	2001-09-11
AU763713B2 (en)	2003-07-31
HUP0102835A3 (en)	2003-09-29
WO2000003014A1 (en)	2000-01-20
NO20010166L (no)	2001-03-06
AP2001002038A0 (en)	2001-03-31
NO20010166D0 (no)	2001-01-10
KR20010071832A (ko)	2001-07-31
EE200100020A (et)	2002-06-17
HUP0102835A2 (hu)	2001-11-28
IS5788A (is)	2000-12-22
AU4791499A (en)	2000-02-01
CN1317045A (zh)	2001-10-10
NZ509174A (en)	2003-08-29
HRP20010025A2 (en)	2001-12-31
EA200100028A1 (ru)	2001-08-27
BR9912018A (pt)	2006-01-31
IL140533A0 (en)	2002-02-10
YU1901A (sh)	2005-06-10
JP2002520020A (ja)	2002-07-09
CA2336805A1 (en)	2000-01-20
ID27742A (id)	2001-04-26
EP1097200A1 (en)	2001-05-09
PL345507A1 (en)	2001-12-17

Similar Documents

Publication	Publication Date	Title
DE69738581D1 (de)	2008-04-30	Menschliche dnase i hyperaktive varianten
DE60140794D1 (de)	2010-01-28	Von casein abgeleitete peptide und deren anwendung für die therapie
DE69826695D1 (de)	2004-11-04	Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
DE69429260D1 (de)	2002-01-10	Adenovirale vektoren tierischen ursprungs und ihre verwendung bei der gentherapie
NZ508505A (en)	2003-04-29	Treatment of wounds using an Egr-1 transcription factor polypeptide
ATE209684T1 (de)	2001-12-15	Dna-sequenzen für matrix-metallproteasen, ihre herstellung und verwendung
ATE368455T1 (de)	2007-08-15	Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
ATE191922T1 (de)	2000-05-15	Feststellung der wechselwirkungsstelle zwischen p21-waf und pcna und deren therapeutischen verwendungen
EP1114862A3 (de)	2003-08-06	Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankungen sowie ihre Verwendung zur Identifizierung von pharmakologisch aktiven Substanzen
WO2003039591A3 (de)	2004-03-11	Allogene vakzine enthaltend eine ein costimulatorisches polypeptid exprimierende tumorzelle
ATE123814T1 (de)	1995-06-15	Gentechnologische menschliche cholinesterasen.
ATE395602T1 (de)	2008-05-15	Verwendung von hmgb-proteinen und dafür codierenden nukleinsäuren
TR199901385T2 (xx)	1999-11-22	Piperidin t�revleri.
YU1901A (sh)	2005-06-10	Upotreba nab1 i nab2 u farmaciji
BR9809712A (pt)	2000-07-11	Formas de dosagem de sertralina em solução encapsulada de gelatina
PT1133296E (pt)	2003-11-28	Nova aplicacao terapeutica da nicergolina
TR199902866T2 (xx)	2000-02-21	Organo- koruyucu aktiviteye sahip yeni BPC peptid tuzlar�, haz�rlanmalar� ve terapide kullan�lmalar� i�in prosesler.
ATE540968T1 (de)	2012-01-15	Alpha-fetoproteinpeptide und deren verwendungen
TR200102265T2 (tr)	2001-12-21	Anestezi düzenlemesi.
EP1083927A4 (en)	2002-01-02	HUMAN "MINOR VAULT" PROTEIN P193
ATE230027T1 (de)	2003-01-15	Menschliche dnase i varianten
ATE328082T1 (de)	2006-06-15	Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen
WO2000026362A3 (de)	2000-06-22	Proteine der stomatinfamilie und ihre verwendung als zielproteine für die schmerztherapie
ES2188754T3 (es)	2003-07-01	Componente b como cicatrizante.
DE69825307D1 (de)	2004-09-02	Verwendung von protein h als zytostattischer wirkstoff